Attached files
| file | filename |
|---|---|
| EX-99 - PRESS RELEASE - ULTRALIFE CORP | newsrelease.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
January 31, 2012
Ultralife Corporation
(Exact name of registrant as specified in its charter)
| Delaware | |
| (State or other jurisdiction of incorporation) |
|
| 000-20852 | 16-1387013 |
| (Commission File Number) | (IRS Employer Identification No.) |
| 2000 Technology Parkway, Newark, New York | 14513 |
| (Address of principal executive offices) | (Zip Code) |
(315) 332-7100
Registrant's telephone number, including area code
| Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): |
||
| [ ] | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
| [ ] | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
| [ ] | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
| [ ] | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | |
Item 8.01. Other Events.
Ultralife Corporation (NASDAQ: ULBI) has received a contract to supply 2,319 of its A-320 amplifier systems to a major international defense contractor. Due to the sensitive nature of this contract, the company is not able to disclose the total value of the contract. Deliveries will commence in the first half of 2012.
The information set forth in this Form 8-K and the attached exhibit is being furnished to and not filed with the Securities and Exchange Commission and shall not be deemed to be incorporated by reference in any filing under the Securities Exchange Act of 1934, as amended, or the Securities Act of 1933, as amended, except to the extent specifically provided in any such filing.
Item 9.01. Financial Statements and Exhibits.
(a)
Exhibits.
99.1 Press Release dated January 31, 2012
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Ultralife Corporation |
||
|
Date: January 31, 2012 |
By: | /s/ PETER F. COMERFORD Peter F. Comerford Vice President of Administration General Counsel and Secretary |
INDEX TO EXHIBITS
| (99) | Additional Exhibits | |
| 99.1 Press Release dated January 31, 2012 |